Fujirebio announced on Thursday that it is acquiring neurodegenerative disease diagnostic company ADx NeuroSciences for €40 million ($42.1 million).

On May 20, the customs statistical data platform updated the import and export data. The export value of China¡¯s COVID-19 reagents in May was 1.394 billion yuan, which is less than 10% of the value in January.

Illumina (Nasdaq:ILMN) announced today that it launched a new research test, co-developed with Merck (NYSE:MRK).

Belgian molecular diagnostics firm Biocartis said on Wednesday that it will develop a molecular test to identify patients with non-small cell lung cancer most likely to respond to AstraZeneca's Tagrisso (osimertinib) treatment.

On June 22, China IPO learned that Mega Genomics (06667.HK) was officially listed on Hong Kong Exchanges and Clearing Limited today.

ProtonDx said on Tuesday that it received a CE-IVD mark for its Dragonfly in vitro diagnostic system.

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands.

Recently, a research team in Thailand said that it was the first case in the world that a cat transmitted novel COVID-19 to humans through sneezing.

Chinese sequencing technology company Axbio said on Monday that it has secured $100 million in Series B financing.

Medix Biochemica, a Finnish producer of raw materials for in vitro diagnostics, said on Monday that it has acquired Bioresource Technology, a US-based provider of base matrices and other raw materials for IVD manufacturing.

On June 16, 2022, Shenzhen Living Water POCT held a strategic investment cooperation signing ceremony with 6 companies including BGI Co-Win, NEVC, Ruihai Invest, VDO Biotech, Zhouyu Fund, Great Wall fund.

Fluent BioSciences and NanoCellect Biomedical said today that they are collaborating to improve the resolution and efficiency of single-cell RNA sequencing (scRNA-seq) analysis of rare cell populations.

FDA has issued an Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines in children as young as six months old.

On June 14, Zhang Wei, CEO & president of Huawei Sports and health product line said that by the end of 2021, Huawei's cumulative global shipments of wearables had exceeded 100 million, and the cumulative global users had exceeded 350 million.

PerkinElmer on Thursday announced it is collaborating with Novartis to expand newborn screening for sickle cell disease in sub-Saharan Africa.

The World Health Organization's COVID-19 Technology Access Pool (C-TAP) initiative has entered into a nonexclusive sublicense agreement with Biotech Africa to manufacture a serology assay to detect previous SARS-CoV-2 infection.

On June 9, 2022, Siemens Healthineers China officially released the company's new "National Intelligence Innovation" localization strategy, announcing that it will deeply participate in Healthy China construction as a "Chinese company" through three demensions.

Thermo Fisher Scientific said on Wednesday that it has received CE-IVD marking for its Ion Torrent Reporter Software Aneuploidy Dx Workflows.

Roche said on Wednesday that the US Food and Drug Administration has issued Emergency Use Authorization for the Cobas SARS-CoV-2 Duo assay.

On June 11, 2022, the signing ceremony of the strategic cooperation between Zhengzhou Autobio Diagnostics Co., Ltd. and Pro-med (Beijing) Technology Co., Ltd. was held in Zhengzhou, and the two parties officially launched the strategic cooperation.